The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Frovatriptan 2.5mg Film-coated Tablets



Chanelle Medical Unlimited CompanyPA0688/027/001

Main Information

Trade NameFrovatriptan 2.5mg Film-coated Tablets
Active SubstancesFrovatriptan succinate monohydrate
Dosage FormFilm-coated tablet
Licence HolderChanelle Medical Unlimited Company
Licence NumberPA0688/027/001

Group Information

ATC CodeN02CC Selective serotonin (5HT1) agonists
N02CC07 frovatriptan

Status

License statusAuthorised
Licence Issued19/07/2013
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back